Sorafenib improves survival in a large multi-center, randomized, placebo-controlled phase III trial in patients with hepatocellular carcinoma

被引：3
|
作者：
Llovet, J. [1 ,2 ]
Mazzaferro, V. [3 ]
Ricci, S. [4 ]
Hilgard, P. [5 ]
Raoul, J. [6 ]
Zeuzem, S. [7 ]
Shan, M. [8 ]
Moscovici, M. [9 ]
Voliotis, D. [10 ]
机构：
[1] Univ Barcelona, IDIBAPSLiver Unit, Barcelona, Spain
[2] Univ Barcelona, BCLC Grp Liver Unit, Barcelona, Spain
[3] Natl Canc Inst, Gastrointestinal Surg Liver Transplant Unit, I-20133 Milan, Italy
[4] St Chiara Univ Hosp, Dept Med Oncol, Pisa, Italy
[5] Univ Hosp Essen, Dept Gestroenterol & Hepatol, Essen, Germany
[6] Ctr Eugene Marquis, Dept Med Oncol, Rennes, France
[7] Univ Frankfurt, Dept Med Oncol, D-6000 Frankfurt, Germany
[8] Bayer Healthcare Pharmaceut, West Haven, CT USA
[9] Bayer Shering Pharma, Milan, Italy
[10] Bayer Shering Pharma, Wuppertal, Germany
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71010-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3507
引用
收藏
页码：261 / 261
页数：1
相关论文
共 50 条
  • [1] Sorafenib improves survival in patients with hepatocellular carcinoma:: Results of a large multi-center, randomized, placebo-controlled phase III trial
    Hilgard, P.
    Trojan, J.
    Galle, P. R.
    Greten, T.
    Erhardt, A.
    Shan, M.
    Moscovici, M.
    Voliotis, D.
    Haeussinger, D.
    [J]. ONKOLOGIE, 2008, 31 : 78 - 78
  • [2] SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
    Zhu, Andrew X.
    Rosmorduc, Olivier
    Evans, T. R. Jeffry
    Ross, Paul J.
    Santoro, Armando
    Carrilho, Flair Jose
    Bruix, Jordi
    Qin, Shukui
    Thuluvath, Paul J.
    Llovet, Josep M.
    Leberre, Marie-Aude
    Jensen, Markus
    Meinhardt, Gerold
    Kang, Yoon-Koo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) : 559 - 566
  • [3] Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
    Llovet, J.
    Ricci, S.
    Mazzaferro, V.
    Hilgard, P.
    Raoul, J.
    Zeuzem, S.
    Poulin-Costello, M.
    Moscovici, M.
    Voliotis, D.
    Bruix, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Randomized phase III trial of sorafenib versus placebo in Asian patients with advanced hepatocellular carcinoma
    Cheng, A.
    Kang, Y.
    Chen, Z.
    Tsao, C.
    Qin, S.
    Kim, J.
    Burock, K.
    Zou, J.
    Voliotis, D.
    Guan, Z. Z.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Fluoxetine treatment of panic disorder: A randomized, placebo-controlled, multi-center trial
    Michelson, D
    Lydiard, RB
    Pollack, MH
    Tamura, R
    Tepner, R
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 : 91S - 92S
  • [6] Final analysis: Randomized, blinded, placebo-controlled phase II trial of sorafenib with and without mapatumumab in patients with advanced hepatocellular carcinoma (HCC).
    Ciuleanu, Tudor-Eliade
    Bazin, Igor
    Lungulescu, Dan
    Miron, Lucian
    Bondarenko, Igor
    Deptala, Andrzej
    Rodriguez-Torres, Maribel
    Giantonio, Bruce J.
    Sun, Weijing
    Fox, Norma Lynn
    Aktan, Gursel
    Wissel, Paul Stephen
    Egger, Jacki
    Ding, Meichun
    Kalyani, Rubana
    Gribbin, Matthew Joseph
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Gemcitabine/cisplatin plus bevacizumab or placebo in advanced malignant mesothelioma: A multi-center, double-blind, placebo-controlled, randomized phase III trial
    Kindler, H
    Lu, C
    Gandara, D
    Stevenson, J
    Krug, L
    Janne, P
    Gitlitz, B
    Karrison, T
    Stadler, W
    Vokes, E
    [J]. LUNG CANCER, 2005, 49 : S28 - S29
  • [8] A Phase Iii Multi-Center, Randomized, Placebo-Controlled, Double-Blind Clinical Trial To Evaluate The Efficacy And Safety Of Desloratadine In Japanese Patients With Chronic Urticaria
    Hisada, S.
    Imai, Y.
    Oshima, N.
    Tanaka, Y.
    Weinstein, C. I.
    Hide, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [9] PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial
    Kitson, Sarah J.
    Maskell, Zoe
    Sivalingam, Vanitha N.
    Allen, Jennifer L.
    Ali, Saad
    Burns, Sean
    Gilmour, Kyle
    Latheef, Rahamatulla
    Slade, Richard J.
    Pemberton, Philip W.
    Shaw, Joseph
    Ryder, W. David
    Kitchener, Henry C.
    Crosbie, Emma J.
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (08) : 2424 - 2432
  • [10] TACE 2: A randomized placebo-controlled, double blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC) Background
    Meyer, Tim
    Fox, Richard
    Ma, Yuk Ting
    Ross, Paul J.
    James, Martin
    Strugess, Richard
    Stubbs, Clive
    Wall, Lucy
    Watkinson, Anthony
    Hacking, Nigel
    Evans, T. R. Jeffry
    Collins, Peter
    Hubner, Richard
    Cunningham, David
    Primrose, John Neil
    Johnson, Philip James
    Palmer, Daniel H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345